In a bleomycin-induced PF model, a previous study found that RGFP966, a specific HDAC3 inhibitor, ameliorated bleomycin-induced PF through regulations of EMT and reduced expression of the proinflammatory cytokines IL-1β and IL-18. This evidence concerns the gene HDAC3 and pemphigus foliaceus.